Xafinact 50 Tablet
Prescription Required
Product introduction
Xafinact 50 Tablet is a medicine used to treat Parkinson's disease. It helps to provide better control of body movements and prevents excessive shaking and stiffness. It increases the concentration of a chemical in the brain called dopamine that plays a major role in movement control.
Xafinact 50 Tablet is used in the treatment of Parkinson’s disease. Xafinact 50 Tablet may be taken alone in the early stages of the condition, delaying the need for the addition of other medicines or with other medicines to reduce the features in later course of the disease
Xafinact 50 Tablet is used in the treatment of Parkinson’s disease. Xafinact 50 Tablet may be taken alone in the early stages of the condition, delaying the need for the addition of other medicines or with other medicines to reduce the features in later course of the disease
Uses of Xafinact Tablet
Benefits of Xafinact Tablet
In Parkinson's disease
Xafinact 50 Tablet is an effective medication to relieve symptoms of Parkinson's disease such as tremors, muscle stiffness and difficulty moving. It increases the amount of a chemical called dopamine in the brain which helps in coordination of body movements. This medicine can therefore enhance the quality of life by improving the ability to carry out daily functions in a better manner.
Side effects of Xafinact Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Xafinact
- Cough
- Depression
- Indigestion
- Flu-like symptoms
- Insomnia (difficulty in sleeping)
- Joint pain
- Peripheral edema
How to use Xafinact Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Xafinact 50 Tablet may be taken with or without food, but it is better to take it at a fixed time.
How Xafinact Tablet works
Xafinact 50 Tablet works by increasing the amount of dopamine, a chemical messenger that is needed to control movement in the brain.
Safety advice
Alcohol
UNSAFE
Xafinact 50 Tablet may cause excessive drowsiness with alcohol.
Pregnancy
CONSULT YOUR DOCTOR
Xafinact 50 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Xafinact 50 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
UNSAFE
Xafinact 50 Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
Xafinact 50 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Xafinact 50 Tablet may not be needed in these patients. Please consult your doctor.
Liver
CAUTION
Xafinact 50 Tablet should be used with caution in patients with liver disease. Dose adjustment of Xafinact 50 Tablet may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Xafinact 50 Tablet
₹6.3/Tablet
Zafimove 50mg Tablet
Torrent Pharmaceuticals Ltd
₹11.5/tablet
83% costlier
Safion 50mg Tablet
Intas Pharmaceuticals Ltd
₹13/tablet
106% costlier
Quick tips
- Xafinact 50 Tablet can be taken with or without food or as directed by your doctor.
- Reduce/avoid a high-protein diet (eg.meat, poultry, and dairy products) while you are taking the medicine as it may cause an unsafe rise in your blood pressure.
- Use caution while driving or doing anything that requires concentration as Xafinact 50 Tablet can make you very sleepy.
- Talk to your doctor in case you develop hallucinations or other changes in your behavior.
- Do not stop taking Xafinact 50 Tablet without first talking to your doctor. Sudden stopping may cause confusion, stiff muscles and a high fever.
Fact Box
Chemical Class
Carboxylic acid and derivatives
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
MAO-B Inhibitors
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Blair HA, Dhillon S. Safinamide: A Review in Parkinson's Disease. CNS Drugs. 2017;31(2):169-176. [Accessed 01 Apr. 2020] (online) Available from:
- Safinamide methansulfonate [EMC SmPC]. Chichester, West Sussex: Profile Pharma Limited; 2015 [revised 19 Sep. 2019]. [Accessed 01 Apr. 2020] (online) Available from:
- Safinamide [FDA Label]. Louisville, KY: US WorldMeds, LLC; 2017. [Accessed 01 Apr. 2020] (online) Available from:
- Drugs.com. Safinamide. [Accessed 01 Apr. 2020] (online) Available from:
Marketer details
Name: Sun Pharmaceutical Industries Ltd
Address: Plot no 107/108,Namli block , Ranipool, East Sikkim 737135
Country of origin: India
Lab tests offered by us
Related/Popular tests
406 people bought this recently₹63
Inclusive of all taxes
MRP₹126 50% OFF
10.0 tablets in 1 strip
SOLD OUT
Notify me